共 38 条
Schistosomiasis Coinfection in Children Influences Acquired Immune Response against Plasmodium falciparum Malaria Antigens
被引:47
作者:
Diallo, Tamsir O.
[1
,2
]
Remoue, Franck
[2
,3
]
Gaayeb, Lobna
[1
,2
]
Schacht, Anne-Marie
[1
,2
]
Charrier, Nicole
[2
]
De Clerck, Dick
[2
]
Dompnier, Jean-Pierre
[2
]
Pillet, Sophie
[2
]
Garraud, Olivier
[4
]
N'Diaye, Abdoulaye A.
[2
]
Riveau, Gilles
[1
,2
]
机构:
[1] Inst Pasteur, INSERM, U547, F-59019 Lille, France
[2] ONG ESPOIR Sante, Lab Rech Med, St Louis, Senegal
[3] IRD, UR Caracterisat & Controle Populat Vecteurs 016, F-34394 Montpellier, France
[4] Univ St Etienne, GIMAP, EA3064, St Etienne, France
来源:
关键词:
MEROZOITE SURFACE PROTEIN-1;
C-TERMINAL FRAGMENT;
IMMUNOGLOBULIN-G;
INFLAMMATORY MARKERS;
ANTIBODY-RESPONSES;
INDIVIDUALS;
SUBCLASSES;
SENEGAL;
MECHANISMS;
INFECTION;
D O I:
10.1371/journal.pone.0012764
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Background: Malaria and schistosomiasis coinfection frequently occurs in tropical countries. This study evaluates the influence of Schistosoma haematobium infection on specific antibody responses and cytokine production to recombinant merozoite surface protein-1-19 (MSP1-(19)) and schizont extract of Plasmodium falciparum in malaria-infected children. Methodology: Specific IgG1 to MSP1-(19), as well as IgG1 and IgG3 to schizont extract were significantly increased in coinfected children compared to P. falciparum mono-infected children. Stimulation with MSP1-(19) lead to a specific production of both interleukin-10 (IL-10) and interferon-gamma (IFN-gamma), whereas the stimulation with schizont extract produced an IL-10 response only in the coinfected group. Conclusions: Our study suggests that schistosomiasis coinfection favours anti-malarial protective antibody responses, which could be associated with the regulation of IL-10 and IFN-gamma production and seems to be antigen-dependent. This study demonstrates the importance of infectious status of the population in the evaluation of acquired immunity against malaria and highlights the consequences of a multiple infection environment during clinical trials of anti-malaria vaccine candidates.
引用
收藏
页码:1 / 7
页数:7
相关论文